BIIB

Biogen

$188.02

-2.71 (-1.42%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$205.67
(+9.39%)
Strong Buy: 2
Buy: 14
Hold: 18
Sell: 1
Strong Sell: 0
Description:
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
225 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
Fiscal year end:
December
Market capitalization:
$28 Billion
EBITDA:
$3.6 Billion
PERatio:
22.23
EPS:
8.58
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
0.164

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-34%
How much will you get:
$659
Prices dates:
29-01-2016: $273.06 and 30-01-2026: $179.89